Dex Liquidating Co (Dex Liquidating Co) ROCE % : 0.00% (As of Sep. 2017)

View and export this data going back to 2006. Start your Free Trial

What is Dex Liquidating Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dex Liquidating Co's annualized ROCE % for the quarter that ended in Sep. 2017 was 0.00%.

Dex Liquidating Co ROCE % Historical Data

The historical data trend for Dex Liquidating Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dex Liquidating Co ROCE % Chart

Dex Liquidating Co Annual Data

Trend

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

ROCE %

Get a 7-Day Free Trial

-100.33

-54.46

-51.92

-76.80

-316.45

Dex Liquidating Co Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
ROCE %	Get a 7-Day Free Trial															-135.54	-178.12	-420.42	-	-

Dex Liquidating Co ROCE % Calculation

Dex Liquidating Co's annualized ROCE % for the fiscal year that ended in Jun. 2017 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2017 )		(A: Jun. 2016 )		(A: Jun. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2017 )		(A: Jun. 2016 )		(A: Jun. 2017 )
	=	-16.677	/	( ( (15.692 - 2.591)	+	(8.871 - 11.432) )	/ 2 )
	=	-16.677	/	( (13.101	+	-2.561)	/ 2 )
	=	-16.677	/	5.27
	=	-316.45 %

Dex Liquidating Co's ROCE % of for the quarter that ended in Sep. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	-13.548	/	( ( (8.871 - 11.432)	+	(6.53 - 12.582) )	/ 2 )
	=	-13.548	/	( ( -2.561	+	-6.052 )	/ 2 )
	=	-13.548	/	-4.3065
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2017) EBIT data.

Dex Liquidating Co (OTCPK:DXTRQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dex Liquidating Co ROCE % Related Terms

Thank you for viewing the detailed overview of Dex Liquidating Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dex Liquidating Co (Dex Liquidating Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Dex Liquidating Co (OTCPK:DXTRQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 West 41st Avenue, Suite 245, San Mateo, CA, USA, 94403

Website

https://www.dexliquidatingco.com

Dex Liquidating Co currently has no business operations.

Executives

Younger William H Jr	other: Former Director	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Newell Robert Y Iv	officer: V.P., Finance, CFO, Secretary	2309 BERING DRIVE, SAN JOSE CA 95131
Liam Burns	officer: VP,Worldwide Sales & Marketing	C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
Gregory D Casciaro	director	361 RAQUEL LANE, LOS ALTOS CA 94022
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
Richard M Ferrari	10 percent owner, other: See Explanation of Responses	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Broadfin Healthcare Master Fund Ltd	10 percent owner, other: See Explanation of Responses	C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Broadfin Capital, Llc	10 percent owner, other: See Explanation of Responses	300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Kevin Kotler	10 percent owner, other: See Explanation of Responses	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Gary S Petersmeyer	director	3400 CENTRAL AVENUE, SANTA CLARA CA 95051
James C Gaither	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Baker G Leonard Jr	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Tench Coxe	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Pullara Samuel J Iii	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Hill Ventures Sutter	10 percent owner	755 PAGE MILL RD, SUITE A200, PALO ALTO CA 94304